CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Once versus three times daily dosing of oral budesonide for active Crohn's disease: a double-blind, double-dummy, randomised trial.
Authors
gasztroenterológus, onkológus) Altorjay István (1954-) (belgyógyász
Stoynov S, Dorofeyev AE, Grigorieva GA, Tomsová E, Altorjay I, Tuculanu D, Bunganič I, Pokrotnieks J, Kupčinskas L, Dilger K, Greinwald R, Mueller R Dignass A
International Budenofalk Study Group
Publication date
21 February 2018
Publisher
'Elsevier BV'
Doi
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
University of Debrecen Electronic Archive
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:dea.lib.unideb.hu:2437/248...
Last time updated on 12/09/2018
